Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply …

Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply …

Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter of intent (“LOI”) with Noramco, Inc., pursuant to which the parties have entered into a ninety-day period during which they will negotiate a […]

Amphastar Pharma (AMPH) Reports FDA Approval for Isoproterenol Hydrochloride Injection, USP

Amphastar Pharma (AMPH) Reports FDA Approval for Isoproterenol Hydrochloride Injection, USP

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has granted approval of its abbreviated new drug application (“ANDA”) for Isoproterenol Hydrochloride Injection, USP 0.2mg/mL, 1mL and 0.2mg/mL, 5mL single dose vial. […]

Alchem International Granted COS by EDQM For Innovative Production Process to Resolve Stability Challenge For …

Alchem International Granted COS by EDQM For Innovative Production Process to Resolve Stability Challenge For …

Alchem International Private Limited (“Alchem”) , a privately held pharmaceutical company focusing on the production of plant derived active pharmaceutical ingredients, today announced the award of European Certificate of Suitability (COS) by European Directorate for the Quality of Medicines ( EDQM) for its innovative manufacturing process for micronized Digoxin overcoming stability, regulatory and formulation issues […]

Glenmark Pharma gets UDFDA nod for first generic out of US facility

Glenmark Pharma gets UDFDA nod for first generic out of US facility

Glenmark Pharmaceuticals received a boost for its plans to manufacture drugs within the US, with the FDA approving the first generic manufacturing application from the facility. The FDA approved the manufacturing of Atovaquone and Proguanil Hydrochloride Tablets at its Monroe, North Carolina facility via a supplementary ANDA (drug application). “This approval is an important milestone for our […]

Global Active Pharma Ingredient Market Outlook 2018- Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China …

Global Active Pharma Ingredient Market Outlook 2018- Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China …

The report on the Global “Active Pharma Ingredient market” offers elaborated knowledge on the Active Pharma Ingredient market. parts like dominating firms, classification, size, business atmosphere, SWOT analysis, and most effectual trends within the business area unit comprised during this analysis study. additionally to the current, the report sports charts, numbers, and tables that provide […]

Record growth at Sterling Pharma Solutions

Record growth at Sterling Pharma Solutions

CRAMLINGTON, UK – Jun 18, 2018 – A UK-based contract development and manufacturing organisation (CDMO) has more than doubled its sales since its formation in 2016 as demand for its hazardous chemistry capabilities and active pharmaceutical ingredient (API) services grows. Sterling Pharma Solutions, which launched as an independent CDMO following a management buyout (MBO) of […]

Active Pharmaceutical Ingredients: Global Markets to 2021 And Playerst

Active Pharmaceutical Ingredients: Global Markets to 2021 And Playerst

All you need to know,new report on “Global Active pharmaceutical ingredient Market will hit around $ 213.84 Billion in 2021” in their database which includes the in-depth analysis and global forecast for the market. The global Active Pharmaceutical Ingredients market report is a systematic study of the global Active Pharmaceutical Ingredients market introducing the advanced state […]